Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03418558
What this trial is testing

Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 13
Not applicableStudy completedNCT02694562
What this trial is testing

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy

Who this might be right for
Colorectal Carcinoma
Boston Scientific Corporation 18
Large-scale testing (Phase 3)Study completedNCT03302234
What this trial is testing

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 568
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802161
What this trial is testing

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia With Multilineage Dysplasia+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05475925
What this trial is testing

DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Who this might be right for
LGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+10 more
Dren Bio 200
Early research (Phase 1)Study completedNCT00516087
What this trial is testing

LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

Who this might be right for
Nasopharyngeal Carcinoma
Baylor College of Medicine 23
Testing effectiveness (Phase 2)Looking for participantsNCT06815497
What this trial is testing

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tyler J Curiel 33
Testing effectiveness (Phase 2)Looking for participantsNCT06941857
What this trial is testing

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Large-scale testing (Phase 3)Study completedNCT03084471
What this trial is testing

An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 867
Not applicableUnknownNCT06479005
What this trial is testing

ETERNALS: Remote Monitoring in Lung Cancer Patients

Who this might be right for
Non-small Cell Lung CancerRemote MonitoringMobile Health+1 more
Ziekenhuis Oost-Limburg 50
Early research (Phase 1)Study completedNCT01453283
What this trial is testing

Tabectedin to Treat Children and Adolescents With Cancer

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00453895
What this trial is testing

Sunitinib in Refractory Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
University of Wuerzburg 39
Early research (Phase 1)Looking for participantsNCT07584954
What this trial is testing

Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Solid Tumor CancerSolid Tumor Cancer Treatment With Immunotherapy
Jun Zhou 90
Not applicableStudy completedNCT01627990
What this trial is testing

Nivestim™ in Treatment of Malignant Diseases

Who this might be right for
Solid TumourMalignant Haematological TumourPrimary or Secondary Prophylactic Treatment
Hospira, now a wholly owned subsidiary of Pfizer 386
Testing effectiveness (Phase 2)UnknownNCT05915481
What this trial is testing

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more
Peking University Third Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT00415909
What this trial is testing

TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 3
Early research (Phase 1)UnknownNCT02602249
What this trial is testing

Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.

Who this might be right for
Gastric Cancer
Beijing Doing Biomedical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00385515
What this trial is testing

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

Who this might be right for
StomatitisOral Mucositis
Mucosal Therapeutics 81
Early research (Phase 1)Active Not RecruitingNCT02264678
What this trial is testing

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

Who this might be right for
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
AstraZeneca 358
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Next Page
49